DNAprint Genomics (DNAG)

[ann441j]

From RB:

Direct access to Quarterly Financials & Interview:

http://brighttalk.com/event/DNAPrint/e2ef524fbf-97-intro
http://www.mn1.com/members/modules.php?name=Downloads&d_op=getit&lid=316

Look at the numbers, dilution is drying up, revenue increasing and share price is stable.

Projected outstanding shares and share price in next 10Q report is 405,767,754 outstanding shares and share price of $0.01616.

Although my opinion this price is seriously undervalued, DNAPrint Genomics is working on a major Genotyping deal which will result in an increased revenue stream, as well the increase in genetic ancestry & genotyping deals will increase. As their focus on forensics is increasing I anticipate forensics will take off again resulting in an increased revenue stream.

I do not have projections of next quarterly financials, however I anticipate they will be above 30% revenue increase upon the 65% of Q2.

Ann